rs121912629
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4PP5
The ENST00000378823.8(RAD50):c.3939A>T(p.Ter1313TyrextTer66) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000378823.8 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD50 | NM_005732.4 | c.3939A>T | p.Ter1313TyrextTer66 | stop_lost | 25/25 | ENST00000378823.8 | NP_005723.2 | |
TH2LCRR | NR_132125.1 | n.105-82T>A | intron_variant, non_coding_transcript_variant | |||||
TH2LCRR | NR_132126.1 | n.175-4099T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD50 | ENST00000378823.8 | c.3939A>T | p.Ter1313TyrextTer66 | stop_lost | 25/25 | 1 | NM_005732.4 | ENSP00000368100 | P1 | |
TH2LCRR | ENST00000435042.1 | n.95-82T>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2021 | The c.3939A>T variant (also known as p.*1313Yext*66), located in coding exon 25 of the RAD50 gene, results from an A to T substitution at nucleotide position 3939, which is the last nucleotide of the RAD50 gene. The stop codon at position 1313 is replaced by Tyrosine, resulting in an elongation of the protein by 66 amino acids. This alteration has been reported in a compound heterozygous state in a patient with Nijmegen breakage syndrome-like disorder (Waltes R et al. Am. J. Hum. Genet., 2009 May;84:605-16). Further analysis by Waltes et al. revealed a protein band of increased molecular weight consistent with this protein elongation; authors conclude that the very low amount of this larger protein was likely a result of either of protein instability or unstable nonstop mRNA. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 05, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in an individual affected with Nijmegen breakage syndrome-like disorder (PMID: 19409520). ClinVar contains an entry for this variant (Variation ID: 5873). This variant is not present in population databases (ExAC no frequency). This sequence change disrupts the translational stop signal of the RAD50 mRNA. It is expected to extend the length of the RAD50 protein by 66 additional amino acid residues. - |
Nijmegen breakage syndrome-like disorder Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2009 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at